Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biohaven Ltd. Common Shares
(NY:
BHVN
)
8.460
+0.370 (+4.57%)
Official Closing Price
Updated: 6:30 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biohaven Ltd. Common Shares
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq
↗
May 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,...
Via
Benzinga
Biohaven's Nurtec Wins FDA Approval As First Med to Prevent and Treat Migraine Attacks
↗
May 28, 2021
The FDA has approved Biohaven Pharmaceutical Holding Co Ltd’s (NYSE: BHVN) dissolvable, Nurtec ODT (rimegepant), for preventive treatment in people who...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 27, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
↗
May 12, 2021
HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in pre-market trading. Needham cut BigCommerce...
Via
Benzinga
Recap: Biohaven Pharma Q1 Earnings
↗
May 10, 2021
Shares of Biohaven Pharma Hldgs (NYSE:BHVN) fell 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 24.27% over the...
Via
Benzinga
36 Biggest Movers From Yesterday
↗
April 08, 2021
Gainers UTime Limited (NASDAQ: UTME) shares jumped 110.7% to close at $82.17 on Wednesday. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share....
Via
Benzinga
Topics
Initial Public Offering
Dow Moves Lower as S&P 500 Eyes New Peak
↗
April 07, 2021
The major benchmarks are relatively flat at midday, as investors await the latest Federal Open Market Committee (FOMC) meeting minutes.
Via
Talk Markets
Topics
Stocks
28 Stocks Moving In Wednesday's Mid-Day Session
↗
April 07, 2021
Gainers UTime Limited (NASDAQ: UTME) jumped 97.4% to $76.99. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share. XL Fleet Corp. (NASDAQ: XL)...
Via
Benzinga
Topics
Initial Public Offering
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
↗
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Biohaven Crushes Forecasts; What's Next For Its Blockbuster Hopeful?
↗
April 07, 2021
Biohaven's pre-announcement for sales of migraine treatment Nurtec ODT crushed Wall Street's expectations Wednesday, leading BHVN stock to surge.
Via
Investor's Business Daily
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today